-Sympathetic receptor stimulation in the brain and hypotensive activity of  -methyldopa.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002415:Cats; D002552:Cerebral Ventricles / Q000187:drug effects; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D005260:Female; D008297:Male; D008750:Methyldopa / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009647:Normetanephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D018492:Dopamine Antagonists; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D009647:Normetanephrine; D015016:Yohimbine; D008750:Methyldopa; D004298:Dopamine; D010646:Phentolamine